Brain

Bright Minds Biosciences to Present at Piper Sandler 37th Annual Healthcare Conference and 2025 AES Annual Meeting

NEW YORK, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Bright Minds Biosciences, Inc. (“Bright Minds,” “BMB” or the “Company”) (NASDAQ: DRUG),…

3 weeks ago

PreveCeutical Medical and BioGene Therapeutics Announce Closing of Plan of Arrangement

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESVancouver, British Columbia--(Newsfile Corp. - November…

3 weeks ago

Kanazawa University research: Scientists develop light-controlled method to trigger brain signals

KANAZAWA, Japan, Nov. 26, 2025 /PRNewswire/ -- Researchers at the Nano Life Science Institute (WPI-NanoLSI), Kanazawa University, report in ACS…

3 weeks ago

Queen Square launches podcast to support Parkinson’s and Essential Tremor patients

LONDON, Nov. 26, 2025 /PRNewswire/ -- Queen Square Imaging Centre – the world-leading centre treating patients with Essential Tremor and…

3 weeks ago

Forest Mountain Farms CBD Gummies Introducing Farms CBD Gummies Natural Anxiety Relief & Joint Pain Relief For Better Sleep 2025

AUSTIN, TX / ACCESS Newswire / November 25, 2025 / Struggling to solve different health issues at the same time,…

3 weeks ago

Jane Fonda to Headline the Livelong Women’s Health Summit in San Francisco

SAN FRANCISCO, Nov. 25, 2025 /PRNewswire/ -- Livelong Media announced today that legendary actress, activist, and women's health advocate Jane…

3 weeks ago

OmniZare to Unveil Revolutionary Dielectric Tomography Scanners at RSNA 2025

Non-Ionizing Technology Makes Medical Imaging Completely Portable and Ultra-AffordableCHICAGO, Nov. 25, 2025 /PRNewswire/ -- RSNA Booth 8100 – OmniZare, an innovative medical…

3 weeks ago

Neurophet and The Florey Strengthen Research Collaboration on ‘Neurophet AQUA’ to Advance Alzheimer’s Disease Diagnosis

Aiming to evaluate the utility of blood-based and other biomarkers for Alzheimer's disease diagnosis and managementJoint research to enhance dementia…

3 weeks ago

Tiziana Life Sciences Nasal Foralumab Phase 2 Clinical Trial Accepted into Healey ALS MyMatch Program

BOSTON, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company…

3 weeks ago

BrainsWay to Host Virtual Analyst & Investor Day to Discuss the Company’s Growth Strategy and Deep TMS™ Treatment December 1, 2025

BURLINGTON, Mass. and JERUSALEM, Nov. 25, 2025 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”),…

3 weeks ago